FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
Last trade$5.00
Day change-$0.23 (-4.40%)
Day range$4.94 – $5.30
Volume3,140,507
Market cap$814M
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$813.57M
Price / earnings
—
Price / book
-41.94×
Price / sales
0.29×
EV / sales
1.51×
EV / EBITDA
-24.86×
Profitability
Earnings per share
-$27.36
Return on assets
-53.8%
Return on equity
21,936.08%
Dividend yield
12.7%
Liquidity and leverage
Debt / equity
-215.35×
Current ratio
1.68×
Quick ratio
1.19×
Cash ratio
0.27×
Cash flow
Price / cash flow
2.32×
Price / free cash flow
2.75×
Free cash flow
$295.6M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for FMC, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$105.9M
$867.1M
$758.6M
$1.08B
$542.2M
$1.05B
$791.4M
$1.22B
Cost of revenue
$507.5M
$525M
$512M
$652.2M
$413.3M
$644.2M
$474.7M
$699.6M
Gross profit
-$401.6M
$342.1M
$246.6M
$431.1M
$128.9M
$406.3M
$316.7M
$524.7M
Selling, general and administrative
$172.3M
$179.1M
$185.1M
$168.7M
$167.4M
$176.8M
$172M
$156.7M
Research and development
$57.7M
$60.4M
$65.5M
$67.7M
$63.3M
$66.4M
$68.7M
$72.2M
Total operating expenses
$710.6M
$461.8M
$327.6M
$1.85B
$525.2M
$279.9M
$258.5M
$290.1M
Operating income
-$1.11B
-$119.7M
-$81M
-$1.42B
-$396.3M
$126.4M
$58.2M
$234.6M
Interest expense
-$73.6M
-$71.3M
-$64.8M
-$64.4M
-$64.1M
-$61M
-$50.1M
-$51.8M
Income before taxes
-$1.19B
-$194.3M
-$149.2M
-$1.48B
-$466M
$58.8M
$4.9M
$177.5M
Income taxes
$840.6M
-$1.5M
$112.1M
$204.1M
$82.2M
$14.4M
$13.5M
$148M
Net income
-$2.07B
-$186.3M
-$281.2M
-$1.72B
-$568.6M
$67.8M
-$15.6M
-$16.1M
Net income attributable to common shareholders
-$2.07B
-$186.6M
-$281.3M
-$1.72B
-$569.3M
$66.7M
-$15.5M
-$16.3M
EBITDA
-$590.7M
$143.7M
$38M
$237.8M
-$58.4M
$206.5M
$119.7M
$338.9M
Basic earnings per share
-$15.54
-$1.49
-$2.25
-$13.74
-$4.52
$0.53
-$0.12
-$0.13
Diluted earnings per share
-$15.54
-$1.49
-$2.25
-$13.79
-$4.52
$0.53
-$0.12
-$0.13
Recent news
Company coverage with links to the original publishers.
Corteva stock plummeted 20.2% after missing Q3 earnings expectations, reporting $0.06 per share instead of the anticipated $0.10, with sales below $1.6 billion versus expected $1.8 billion. The miss was driven by rapid price declines in agricultural chemicals, particularly in Latin America where sales fell 28% year-over-year. Management expects challenging market conditions ahead, especially in Brazil, though full-year guidance remains between $0.76-$0.80 per share on an adjusted basis—below Wall Street's GAAP expectations of $0.82.
Pomerantz LLP is investigating potential securities fraud claims on behalf of FMC Corporation investors. On October 15, 2026, FMC issued revised guidance showing significantly lower revenue expectations ($65-125M) and negative EBITDA ($510-565M), citing $625-675M in commercial actions to lower product prices. The announcement triggered a 30.53% stock price decline to $5.62 per share.
Pomerantz LLP is investigating potential securities fraud claims against FMC Corporation following a significant stock price decline. On October 15, 2026, FMC issued revised guidance showing expected revenue between $65-125 million and negative EBITDA of $510-565 million, citing $625-675 million in commercial actions to lower product prices. The announcement caused FMC's stock to plummet 30.53% to $5.62 per share.
FMC Corporation reported a Q3 2026 adjusted loss of $4.41 per share, missing estimates, with revenues down 80.5% year-over-year due to commercial adjustments and weaker demand. The company lowered its full-year 2026 revenue guidance to $2.75B-$2.85B (28% decline) and now expects negative free cash flow of $150M-$350M, reflecting softer market conditions and pricing restructuring impacts.
FMC reported a quarterly loss of $4.41 per share versus consensus estimate of $0.08, representing a -5,612.50% earnings surprise. The company's stock has declined 67.8% year-to-date, significantly underperforming the S&P 500's 13.1% gain. FMC received a Zacks Rank #5 (Strong Sell) rating due to unfavorable estimate revisions, with the Agriculture - Operations industry ranking in the bottom 11% of sectors.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Sep 30, 2026
$0.08
Oct 15, 2026
recurring
Jun 30, 2026
$0.08
Jul 16, 2026
recurring
Mar 31, 2026
$0.08
Apr 16, 2026
recurring
Dec 31, 2025
$0.08
Jan 15, 2026
recurring
Sep 30, 2025
$0.58
Oct 16, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.